Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Hasenburg, Annette; Sehouli, Jalid; Lampe, Boern et al.
LION-PAW: Lymphadenectomy in ovarian neoplasm-pleasure ability of women-Prospective substudy of the randomized multicenter LION study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018
Reinisch, M.; Seiler, S.; Hauzenberger, T. et al.
Male-GBG54: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen plus /- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor plus GnRHa in male breast cancer patientsCANCER RESEARCH. Bd. 78. H. 4. 2018
Thill, Marc; Schmidt, Marcus
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancerTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. Bd. 10. 2018
Eckes, L.; Droge, L. A.; Fullborn, T. et al.
Management of patients with gynecological sarcoma - a survery among gynecologists within the framework of the German Registry of Gynecological Sarcoma (REGSA)ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 194-195
Moebus, Volker; Noeding, Stefanie; Ladda, Ekkehart et al.
Neo-/adjuvant phase III trial to compare intense dose-dense (idd) treatment with EnPC to tailored dose-dense (dt) therapy with dtEC-dtD for patients with high-risk early breast cancer: Results on pathological complete response (pCR) for patients treated within the neoadjuvant setting.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018
Ackermann, S; Dannecker, C; Horn, L-C et al.
Operative Therapie des PrimärtumorsSchnürch, Hampl, Wöler (Hrsg). Tumorerkrankungen der Vulva und Vagina. 1. Aufl. Berlin: Springer 2018
de Gregorio, N.; Harter, P.; Kimmig, R. et al.
Overall survival results of AGO-OVAR 12, a randomized placebo-controlled multinational phase III trial with chemotherapy plus /- nintedanib in patients with advanced primary ovarian cancerONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 88-88
Schmidt, M; Sebastian, M
Palbociclib -The First of a New Class of Cell Cycle InhibitorsRecent Results Cancer Res. Bd. 211. 2018 S. 153-175
Schmidt, M; Sebastian, M
Palbociclib – the first of a new class of cell cycle inhibitors. In Small Molecules in OncologyMartens (Hrsg). Small Molecules in Oncology. Springer 2018
Schmidt, M.; Gerlach, C.
Palliative medical measures for gynecological malignancies and breast cancer according to S3 guidelinesGYNAKOLOGE. Bd. 51. H. 10. 2018 S. 859-869